| Literature DB >> 25237427 |
Min-Ho Jung1, Kyung-Sub Moon1, Kyung-Hwa Lee2, Woo-Youl Jang1, Tae-Young Jung1, Shin Jung1.
Abstract
OBJECTIVE: Based on surgical outcomes of patients with infratentorial meningiomas surgically treated at our institution, we analyzed the predictors for surgical resection, recurrence, complication, and survival.Entities:
Keywords: Complication; Infratentorial; Intracranial meningioma; Recurrence; Surgical outcome; Survival
Year: 2014 PMID: 25237427 PMCID: PMC4166327 DOI: 10.3340/jkns.2014.55.6.321
Source DB: PubMed Journal: J Korean Neurosurg Soc ISSN: 1225-8245
Clinical characteristics of 158 patients with infratentorial meningiomas
*Group I : cerebellopontine angle and cerebellar convexity, Group II : tentorial & peritorcular, Group III : skull base locations including petroclival, foramen magnum, and jugular foramen. WHO : World Health Organization, KPS : Karnofsky performance scale
Univariate and multivariate analysis for resection predictors in patients with infratentorial meningiomas
*No stem sign : headache, dizziness, seizure, Stem sign : mental changes, motor weakness, cranial nerve deficit, †Group I : cerebellopontine angle & cerebellar convexity, Group II : tentorial & peritorcular, Group III : skull base locations including petroclival, foramen magnum, and jugular foramen, ‡Reference variable : non-skullbase location groups (Group I+II). Cx : complication, KPS : Karnofsky performance scale, NA : non-available, ND : non-detected, WHO : World Health Organization
Fig. 1Overall recurrence-free survival. The incidence of recurrence rate is 13.3% (21/158) with the mean recurrence time of 149.7 months 95% confidence index : 128.3--171.2 months, the median recurrence time has not reached.
Fig. 2Kaplan-Meier analysis of recurrence-free survival for enrolled patients according to independent predictors on multivariate analysis (overall comparison was estimated using a log-rank test). A : Peritumoral edema. B : Simpson's grade. C : Pathology. D : Postoperative Karnofsky performance scale.
Univariate and multivariate analysis for recurrance predictors in patients with infratentorial meningiomas
*No stem sign : headache, dizziness, seizure, Stem sign : mental changes, motor weakness, cranial nerve deficit, †Group I : cerebellopontine angle & cerebellar convexity, Group II : tentorial & peritorcular, Group III : skull base location including petroclival, foramen magnum, and jugular foramen, ‡Reference variable : non-skullbase location groups (Group I+II). Cx : complication, KPS : Karnofsky performance scale, ND : non-detected, WHO : World Health Organization
Fig. 3Overall survival. The incidence of death rate was 5.0% (8/158) with the mean survival time of 224.1 months 95% confidence index : 211.3-237.0 months, the median survival time was not reached.
Fig. 4Kaplan-Meier analysis of overall survival for enrolled patients according to independent predictors on multivariate analysis (overall comparison was estimated using a log-rank test). A : Simpson's grade. B : Pathology. C : Postoperative Karnofsky performance scale.
Univariate and multivariate analysis for death predictors in patients with infratentorial meningiomas
*No stem sign : headache, dizziness, seizure, Stem sign : mental changes, motor weakness, cranial nerve deficit, †Group I : cerebellopontine angle & cerebellar convexity, Group II : tentorial & peritorcular, Group III : skull base location including petroclival, foramen magnum, and jugular foramen, ‡Reference variable : non-skullbase location groups (Group I+II). Cx : complication, KPS : Karnofsky performance scale, ND : non-detected, WHO : World Health Organization
Univariate and multivariate analysis for permanent complication predictors in patients with infratentorial meningiomas
*No stem sign : headache, dizziness, seizure, Stem sign : mental changes, motor weakness, cranial nerve deficit, †Group I : cerebellopontine angle & cerebellar convexity, Group II : tentorial & peritorcular, Group III : skull base location including petroclival, foramen magnum, and jugular foramen, ‡Reference variable : non-skullbase location groups (Group I+II). Cx : complication, KPS : Karnofsky performance scale, ND : non-detected, WHO : World Health Organization